Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 7/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.60 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.56 |
| ▸ | PRKACA | P17612 | 3/20 | 0.54 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 0.54 |
| ▸ | GSK3B | P49841 | 3/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 6/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28236159 | 0.90 | CYP11B2 (0.63) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| SCHEMBL31267414 | 0.80 | RPS6KB1 (0.62) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7183988 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7175678 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7175670 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7182759 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7175207 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7175623 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| Hydrochloric Acid SCHEMBL7185555 | 0.78 | RPS6KB1 (0.56) | HDAC1HDAC8HDAC6CYP11B2PRKACA | |
| SCHEMBL29056722 | 0.76 | CYP11B2 (0.54) | HDAC1HDAC8HDAC6CYP11B2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130270541-A1 | IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20130270541-A1 | IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130270541-A1 | IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | NFXL1, NFE2L2, ZC3HAV1L | HDAC1 809/4885HDAC8 1335/4885HDAC6 3919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.